메뉴 건너뛰기




Volumn 148, Issue 6, 2012, Pages 1081-1084

Antibody-based immunotherapy of cancer

Author keywords

[No Author keywords available]

Indexed keywords

4 1BB AGONIST ANTIBODY; ANGIOGENESIS INHIBITOR; ANTIBODY CONJUGATE; BISPECIFIC ANTIBODY; BISPECIFIC T LYMPHOCYTE ENGAGER ANTIBODY; BL 22; BRENTUXIMAB VEDOTIN; CAPECITABINE; CATUMAXOMAB; CETUXIMAB; CVX 241; DACARBAZINE; ERTUMAXOMAB; FC RECEPTOR; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOTOXIN; IPH 2101; IPILIMUMAB; IRINOTECAN; LAPATINIB; MDX 1106; MEHD 7945A; MM 111; MONOCLONAL ANTIBODY; OX40 AGONIST ANTIBODY; PANITUMUMAB; TRASTUZUMAB EMTANSINE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

EID: 84858416256     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.02.034     Document Type: Review
Times cited : (236)

References (20)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.